Single cell genome anomaly detection method and kit
Enzyme cleavage was terminated by formaldehyde-EGS cross-link fixation and high-temperature incubation, combined with the use of thioddNTPs and phi29 DNA polymerase, and the problem of operation complexity and low resolution in single-cell genomic abnormality detection technology was solved, achieving high coverage and high success rate test results.
Patent Information
- Application Number
- CN202411166990.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-23
- Publication Date
- 2024-11-29
AI Technical Summary
The existing single-cell genomic abnormality detection technology has cumbersome operation, high cost, low success rate, poor fidelity of amplified fragments, low gene coverage, poor uniformity, high detection noise, high false positives, low detection resolution and effective detection The problem of low fragment ratio.
Two cross-linking fixation was performed using formaldehyde and EGS, traditional centrifugation was removed to terminate the enzyme cleavage reaction, high-temperature incubation was used to terminate the enzyme cleavage reaction, and thioddNTPs and phi29 DNA polymerase were introduced into the single-cell genome amplification system to ensure the amplification product High coverage and fidelity.
It improves detection resolution, reduces false positives and noise, improves experimental success rate and genome coverage, simplifies the operation process, and enhances the accuracy and reliability of the detection results.
Smart Images

Figure CN119040472A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of molecular biology, and in particular to a method and a kit for detecting single-cell genome abnormality. Background Art
[0002] With the deepening of molecular biology and genomic research, the detection of genomic abnormalities, including genomic structural variation (SV), copy number variation (SNV), local amplification, single nucleotide polymorphism (SNP), genomic insertion, deletion (INDEL) and mutation, has become an important means of disease diagnosis and treatment. At present, the detection of genomic abnormalities mainly relies on the in situ Hi-C detection method based on 3C technology. Hi-C technology captures and analyzes the three-dimensional conformation of the genome in the cell nucleus, reveals abnormal changes within the genome, and provides important molecular mechanism information for the occurrence and development of the disease.
[0003] However, traditional Hi-C technology usually requires a large number of cells to obtain enough DNA fragments for analysis. However, because cells in patients with cancer and other diseases often have strong heterogeneity, in situ Hi-C detection methods under a large number of cell populations cannot explore differences between cells, and the averaged detection results cause genomic abnormalities in a small number of cells to be covered or missed. Therefore, single-cell Hi-C technology came into being.
[0004] In 2017, scientists constructed the first single-cell Hi-C detection method (scHi-C), but the technology has the problems of cumbersome operation, high cost and low success rate; in the same year, Ilya M. Flyamer et al. established the single-cell nuclear Hi-C technology (snHi-C), which uses the MDA amplification method to ensure the fidelity of the amplified samples. However, the traditional MDA amplification method has an amplification preference for some genes, resulting in low gene coverage, poor uniformity, and poor amplification effect. In 2018, Professor Xie Xiaoliang's team published the latest research on single-cell Hi-C detection technology (Dip-C) in Science, which uses a transposon-based whole genome amplification method-multiple end-labeling amplification (Meta) technology for single-cell amplification to improve resolution and reduce false positives, but after application, it was found that the technology has not achieved significant improvement in detection result coverage, effective fragment quantity, etc.; in 2021, Professor Xie Xiaoliang's team further improved the Meta method and constructed the Meta-ES detection technology, but the detection effect in terms of gene coverage and uniformity is still not ideal; in 2023, Professor Xing Dong's team integrated MALBAC amplification technology into single-cell chromatin conformation and genomic abnormality detection, but there are still problems such as poor fidelity and coverage of amplified fragments. Summary of the invention
[0005] In view of the above technical problems, the present invention provides a single-cell genome abnormality detection method and kit. The method of the present invention improves the cross-linking strength and stability of the sample by successively using formaldehyde and EGS for two cross-linking fixations, which can effectively avoid nonspecific cross-linking phenomena, reduce detection noise and false positive phenomena; and in view of the premise that the two cross-linking fixations ensure the cross-linking strength and stability of the sample, the traditional method of using centrifugation to terminate the enzyme cleavage reaction is removed, and high-temperature incubation is used to terminate the enzyme cleavage reaction, which is used to avoid the phenomenon that cells are prone to adhesion and agglomeration in the traditional centrifugation step, reduce data confusion caused by cell adhesion, poor data quality, and false positives or false negatives, and reduce the difficulty of single-cell separation operation experiments; at the same time, the single-cell genome amplification system is improved to obtain a high-coverage, non-biased and high-fidelity amplified samples, and finally obtain a single-cell genome abnormality detection method with high detection resolution and accurate detection results, and the experimental operation difficulty is low and the success rate is high.
[0006] Based on the above, the present invention first provides a single cell genome abnormality detection method, comprising the following steps:
[0007] S1, cross-linking fixation: formaldehyde is added to the sample for primary cross-linking fixation, and then EGS is added for secondary cross-linking fixation to obtain a cross-linked fixed sample;
[0008] S2, lysis: performing cell membrane lysis treatment on the cross-linked fixed sample;
[0009] S3, enzyme digestion: adding restriction endonucleases to the cell membrane lysed samples for enzyme digestion reaction to fragment the samples, and high temperature incubation is used to terminate the enzyme digestion reaction;
[0010] S4, end repair and proximity ligation: repair the DNA ends of the fragmented samples and reconnect the adjacent DNA fragments using DNA ligase;
[0011] S5, single cell separation: separate single cells and complete cell nucleus lysis to obtain single cell lysate;
[0012] S6, sample amplification and fragment sorting: adding an amplification system to the single cell lysate to amplify DNA, and obtaining a sorted amplified sample after purification and fragment sorting;
[0013] S7, library construction and sequencing analysis: library construction and sequencing analysis are performed on the amplified samples after sorting.
[0014] Preferably, in step S6, the fragment size of the amplified sample after sorting is 300bp-400bp;
[0015] Wherein, the amplification system comprises: dNTPs, thio-ddNTPs, and phi29 DNA polymerase.
[0016] Preferably, the method comprises the following specific steps:
[0017] S1, cross-linking fixation: collect cell samples, wash and resuspend with PBS solution, add formaldehyde solution with a final concentration of 1% v / v, incubate at room temperature for 10 minutes, add BSA solution with a final concentration of 1% w / v to terminate the primary cross-linking fixation; after centrifugation and washing, add 10 μL 100 mM EGS solution, incubate at room temperature for 20 minutes, add glycine solution with a final concentration of 200 mM to terminate the secondary cross-linking fixation, centrifuge and collect the precipitate to obtain the cross-linked fixed sample;
[0018] S2, lysis: add 200 μL of pre-cooled first lysis solution and 5 μL of protease inhibitor to the cross-linked fixed sample to preliminarily lyse the cell membrane; after centrifugation to remove the supernatant, add 200 μL of 0.5% w / v sodium dodecyl sulfate solution, incubate on ice for 3 minutes after 10 minutes in a 65°C water bath to completely lyse the cell membrane; then add 100 μL of pre-cooled 5% v / v Triton X-100, incubate on ice for 5 minutes to terminate the lysis;
[0019] S3, enzyme digestion: add an enzyme digestion system containing restriction endonucleases to the product of step S2, mix well, incubate at 37°C overnight to fragment the sample, and terminate the enzyme digestion reaction by incubating at 65°C for 20 minutes;
[0020] S4, end repair and adjacent ligation:
[0021] Add the end repair system to the enzyme digestion product and react at 37°C for 1 hour to complete the end repair;
[0022] Add a ligation reaction system containing DNA ligase to the end repair product and react overnight at room temperature to reconnect adjacent DNA fragments;
[0023] S5, single cell separation: wash and resuspend the product of step S4 with PBS solution, use a capillary to draw 0.5 μL of single cells and add them to a PCR tube, add the second lysis solution, heat treat at 72°C for 10 min to complete cell nuclear lysis, and obtain single cell lysate;
[0024] S6, sample amplification, purification and fragment sorting: adding the amplification system to the single cell lysate, amplifying at 42° C. for 2 h, purifying the product and sorting the fragments to obtain a sorted amplified sample;
[0025] S7, library construction and sequencing analysis: library construction and sequencing analysis are performed on the sorted samples.
[0026] Preferably, in step S3, the restriction endonuclease comprises any one of MboI, HindIII, DpnII, NcoI, EcoRI, and NlaIII; in step S4, DNA end repair is completed using any one of DNA polymerase I large fragment, Taq DNA polymerase, or DNA polymerase I; and the DNA ligase comprises T4 DNA ligase.
[0027] Preferably, the first lysing solution comprises: 10 mM Tris, 10 mM NaCl and 0.2% w / v ethylphenyl polyethylene glycol; the second lysing solution comprises: 200 mM NaOH and 50 mM dithiothreitol.
[0028] On the other hand, the present invention also provides a single-cell genome abnormality detection kit, which comprises: formaldehyde, EGS, dNTPs, thio-ddNTPs, and phi29 DNA polymerase.
[0029] Preferably, the kit further comprises: MboI restriction endonuclease, DNA polymerase I large fragment, T4 DNA ligase, random primers and buffer required for PCR amplification.
[0030] Preferably, the sequence of the random primer is NNNN*N*N, where * represents thiolation modification and N represents any nucleotide.
[0031] Another aspect of the present invention also provides the use of the aforementioned kit in single-cell genome abnormality detection.
[0032] Compared with the prior art, the beneficial effects of the present invention include at least:
[0033] The present invention provides a method and kit for detecting abnormality of a single cell genome. The detection method of the present invention uses formaldehyde and EGS to perform cross-linking fixation on the sample twice, thereby improving the cross-linking strength and stability, avoiding non-specific cross-linking caused by subsequent de-cross-linking, thereby reducing detection noise and false positive phenomena; and in view of the premise that the two cross-linking fixations ensure the cross-linking strength and stability of the sample, the traditional method of using centrifugation to terminate the enzyme cleavage reaction is removed, and high-temperature incubation is used to terminate the enzyme cleavage reaction, which is used to avoid the phenomenon that cells are prone to adhesion and aggregation in the traditional centrifugation step, reduce data confusion, poor data quality, and false positives or false negatives caused by cell adhesion, and reduce the difficulty of single cell separation operation experiments; in the process of single cell genome amplification, by introducing thio ddNTPs to bind to the amplification product to terminate the amplification, a high coverage, non-preferential amplification sample is obtained, thereby improving the detection resolution and the effective detection fragment ratio, reducing noise and false positives; at the same time, phi29 DNA polymerase is used for amplification to ensure the fidelity of the amplification product; in addition, the terminal biotin labeling and streptavidin adsorption steps are removed in the detection step of the present invention, which not only saves experimental costs, but also reduces the difficulty of operation and improves the success rate of the experiment. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] Figure 1 This is an operational flow chart of the single-cell genome abnormality detection method of the present invention (hereinafter also referred to as Uni-C technology).
[0035] Figure 2 DNA gel electrophoresis was used to identify the efficiency of chromosome fragmentation by MboI.
[0036] Figure 3 DNA gel electrophoresis was used to identify the efficiency of chromosome end proximity joining.
[0037] Figure 4 DNA gel electrophoresis was used to identify single-cell genome amplification efficiency.
[0038] Figure 5 The library construction results of the single-cell genome abnormality detection method of the present invention are identified by DNA gel electrophoresis.
[0039] Figure 6 Chromatin interaction matrices for local amplification of the genome of single cells and a large number of cells;
[0040] A is an interactive heat map of local genomic amplification detected by MGA-seq in a large number of cells;
[0041] B is an interactive heat map of local amplification of single-cell genome detected using Uni-C technology.
[0042] Figure 7 The result diagram of gene copy number abnormality in single cells and a large number of cells; among them:
[0043] A is the abnormal result of gene copy number detected by MGA-seq in a large number of cells;
[0044] B is the result of detecting single-cell gene copy number abnormalities using Uni-C technology.
[0045] Figure 8 This is the SNP / Indel detection result diagram; where:
[0046] A is a Venn diagram comparing the SNP / Indel detection results of a large number of cells and single cells;
[0047] B is the result of detecting SNP / Indel on chromosome 1 in cells using MGA-seq;
[0048] C is the result of detecting SNP / Indel on chromosome 1 in cells using Uni-C technology.
[0049] Fig. 9 Heatmaps of genomic structural variation in single cells and a large number of cells;
[0050] A is the result of detecting genome structural variation using Uni-C technology;
[0051] B is the result of detecting genomic structural variation in a large number of cells using MGA-seq:
[0052] C is the structural variation type corresponding to the heat map of different results.
[0053] Fig.10 To construct and compare chromatin interaction matrices for various detection methods;
[0054] A is a heat map of chromatin interactions detected using Uni-C technology;
[0055] B is a heat map of chromatin interactions detected using the existing method Method A.
[0056] Fig.11 Comparison of genome coverage of various detection methods.
[0057] Fig.12 Comparison of the proportion of effective interaction fragments after redundancy removal using various detection methods.
[0058] Fig.13 Comparison of remote interaction ratios for various detection methods.
[0059] In the accompanying drawings, Uni-C refers to the single-cell genome abnormality detection method of the present invention; Method A refers to the existing method DIP-C; Method B refers to the existing method HIRES. DETAILED DESCRIPTION
[0060] The technical solution of the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments.
[0061] As mentioned earlier, in order to complete genomic abnormality detection at the single-cell level, researchers have designed and developed a series of single-cell genomic abnormality detection methods based on in situ Hi-C technology in large cell populations. However, these technologies still have some defects, such as: complex experimental operations and low success rates; poor fidelity of amplified fragments, low gene coverage, and poor uniformity; large detection noise and high false positives; low detection resolution and low proportion of effectively detected fragments, which have limited the application of these technologies.
[0062] In order to solve the above technical problems, the inventors of the present application have made at least the following improvements after a lot of designs and experiments: (1) Twice cross-linking and fixing samples: The samples are cross-linked and fixed twice with formaldehyde and EGS respectively, so as to improve the cross-linking strength and stability of protein-nucleic acid and protein-protein interactions, improve the cross-linking effect, reduce the risk of non-specific cross-linking caused by decomposition of cross-links during subsequent high-temperature termination of enzyme cleavage, suppress the occurrence of noise and false positives, and improve detection accuracy and the proportion of effectively detected fragments; (2) Preventing cell adhesion: After the enzyme cleavage reaction is completed, the prior art uses a centrifugation step to remove the enzyme cleavage solution to terminate the reaction, but the centrifugal force causes cell adhesion, which not only increases the difficulty of subsequent single-cell separation operations, but also leads to the loss of sample heterogeneity. To solve this problem, the present invention uses high-temperature incubation to terminate the enzyme cleavage reaction based on the premise of enhancing the cross-linking strength by the aforementioned two cross-linking fixations, thereby avoiding cell adhesion caused by centrifugal force and preventing the sample from de-crosslinking under high temperature environment; (3) Optimizing the sample amplification system: During the amplification of single-cell lysate, thio-ddNTPs are introduced to bind to the amplified product to terminate the amplification, thereby obtaining a high-coverage, non-biased amplified sample to improve the detection resolution and the effective detection fragment ratio, and reduce noise and false positives; at the same time, phi29 DNA polymerase is used for amplification to ensure the fidelity of the amplified product. Finally, a single-cell genome abnormality detection method with high detection resolution and accurate detection results is provided, and the experimental operation difficulty is low and the success rate is high.
[0063] Based on the above, the present invention first provides a single cell genome abnormality detection method, comprising the following steps:
[0064] S1, cross-linking fixation: After adding formaldehyde to the sample for primary cross-linking fixation, EGS is added for secondary cross-linking fixation to obtain a cross-linked fixed sample.
[0065] This step is used to coagulate the proteins involved in chromatin interaction in the genome to stabilize the three-dimensional structure of chromatin. This step is crucial for subsequent chromatin structure analysis. The prior art usually uses formaldehyde treatment, but the present invention has been found through experiments that the sample treated with formaldehyde still has poor sample cross-linking effect, and is prone to de-crosslinking in subsequent experiments, thereby causing non-specific cross-linking, noise and false positives, and ultimately leading to poor detection resolution and low effective detection fragments. Results. More importantly, unlike the prior art method of using a centrifugation step to remove the enzyme digestion solution to terminate the enzyme digestion reaction, the present invention is designed to terminate the enzyme digestion reaction by high temperature incubation in order to avoid cell adhesion caused by centrifugal force, and the high temperature environment is more likely to damage the structure of the interaction between chromatin, making it easier for cross-linked fixed samples to de-crosslink, so the present invention is in order to solve the de-crosslinking phenomenon that occurs in subsequent high temperature environments, and puts forward higher requirements for the fixed cross-linking strength of the early samples.
[0066] After a large number of experiments, the applicant analyzed that the reason for the poor effect of traditional formaldehyde cross-linking may be that the principle of formaldehyde cross-linking is to react with the amino groups in proteins (mainly the ε-amino group on the side chain of lysine) to form a methylene bridge (-CH2-) connection, and it can also react with nucleic acids and other molecules containing active hydrogen atoms. Therefore, formaldehyde cross-linking is relatively weak and reversible, resulting in poor cross-linking strength and stability.
[0067] Based on the above findings and analysis, after a large number of experiments and verifications, the present invention finally adopted the formaldehyde-EGS double cross-linking mode to perform two cross-linking fixations on the samples. Among them, the formaldehyde added first can provide short-range cross-linking to ensure that the tight interactions inside the chromatin are fixed, and the EGS added later provides long-range cross-linking to ensure that the long-range chromatin interactions are fixed. The combined use of these two cross-linking agents can capture various chromatin interactions from short to long ranges, enhance the cross-linking effect, and improve the comprehensiveness and quality of the data. In addition, the broad reactivity of formaldehyde can ensure that various types of biological molecules are effectively cross-linked, and the specific reaction of EGS can enhance the cross-linking effect between specific proteins, making the analysis more targeted. It should be emphasized that the present invention has been experimentally proven that the order of using formaldehyde and EGS cannot be changed at will. Specifically, if EGS is added first and then formaldehyde is added, since the cross-linking effect of EGS on DNA and protein is not as good as that of formaldehyde, the combination of the two may be destroyed during the treatment period, resulting in the failure of subsequent experiments; however, formaldehyde and EGS cannot be added at the same time. The experimental exploration of the present invention found that the formaldehyde treatment time should be short, and a long treatment time will result in the inability to break the cell membrane later; and the EGS treatment time cannot be too short, and a short time cannot enhance the cross-linking effect. In other words, since the cross-linking time of formaldehyde and EGS is different, and both need to be terminated immediately after cross-linking, adding treatment at the same time will lead to any of the following adverse results: the formaldehyde cross-linking time is long, resulting in the inability to break the cell membrane; or the EGS cross-linking time is short, which cannot enhance the cross-linking effect.
[0068] In some embodiments, in this step, after the primary cross-linking fixation, BSA is used to terminate the primary cross-linking fixation reaction; then a secondary cross-linking fixation is performed, and glycine is used to terminate the secondary cross-linking fixation to obtain the cross-linked fixed sample.
[0069] In some embodiments, the specific operation of this step is: collect the cell sample, wash and resuspend with PBS solution, add formaldehyde solution with a final concentration of 1% v / v, incubate at room temperature for 10 minutes, add BSA solution with a final concentration of 1% w / v to terminate the primary cross-linking fixation; after centrifugation and washing, add 10 μL 100 mM EGS solution, incubate at room temperature for 20 minutes, add glycine solution with a final concentration of 200 mM to terminate the secondary cross-linking fixation, take the precipitate after centrifugation, and obtain a cross-linked fixed sample.
[0070] S2, lysis: performing cell membrane lysis treatment on the cross-linked fixed sample.
[0071] This step is used to lyse the cell membrane. If the cell membrane is not lysed, the enzymes added in subsequent experiments such as enzyme digestion, end-filling, and proximity ligation will not be able to enter the cell to play a corresponding role, resulting in experimental failure.
[0072] In some embodiments, the specific operation of this step is: add 200 μL of pre-cooled first lysis solution and 5 μL of protease inhibitor to the cross-linked fixed sample to preliminarily lyse the cell membrane; after centrifugation to remove the supernatant, add 200 μL of 0.5% w / v sodium dodecyl sulfate solution, bathe at 65°C for 10 minutes, incubate on ice for 3 minutes, and completely lyse the cell membrane; then add 100 μL of pre-cooled 5% v / v Triton X-100, incubate on ice for 5 minutes, and terminate the lysis. Wherein, the first lysis solution contains: 10mM Tris, 10mM NaCl and 0.2% w / v ethylphenyl polyethylene glycol.
[0073] S3, enzyme digestion: Add restriction endonucleases to the cell membrane lysed sample for enzyme digestion to fragment the sample, and terminate the enzyme digestion reaction by high temperature incubation.
[0074] This step uses restriction endonucleases to cut the genome and produce DNA fragments of a specific size. It should be emphasized that thanks to the formaldehyde-EGS double cross-linking mode adopted in step S1 of the present invention, it can prevent the structure of chromatin interactions from being destroyed in a high temperature environment. Therefore, when terminating the enzyme cleavage reaction in this step, high-temperature incubation can be used to terminate the enzyme cleavage reaction, and the method of centrifugation to remove the enzyme cleavage system can be avoided, thereby effectively preventing the problem of sample cell adhesion and aggregation caused by centrifugal force. Sample cell adhesion and aggregation will increase the difficulty of subsequent single cell separation operations, and even cause single cell separation failure and loss of sample heterogeneity.
[0075] In some embodiments, the specific operation of this step is: adding a restriction endonuclease digestion system to the product of step S2, mixing evenly, incubating at 37°C overnight to fragment the sample, and incubating at 65°C for 20 minutes to terminate the digestion reaction. The restriction endonuclease includes any one of MboI, HindIII, DpnII, NcoI, EcoRI, and NlaIII.
[0076] S4, end repair and proximity ligation: DNA ends of fragmented samples are repaired and adjacent DNA fragments are reconnected using DNA ligase.
[0077] This step first repairs the ends of the cut DNA fragments to ensure that all fragments have ends suitable for connection; then the ends of adjacent DNA fragments in the chromatin interaction region are connected to form a linear or circular structure.
[0078] In some embodiments, the specific operation of this step is: add the end repair system to the enzyme digestion product of step S3, react at 37°C for 1 hour to complete the end repair; add the ligation reaction system containing DNA ligase to the end repair product, react at room temperature overnight to reconnect the adjacent DNA fragments. Wherein, the end repair system is composed of dNTPs, any one of DNA polymerase I large fragment, Taq DNA polymerase or DNA polymerase I, end repair buffer and ultrapure water; the ligation reaction system is composed of T4 DNA ligase, Triton X-100, ligation buffer and ultrapure water.
[0079] It should be emphasized that the present invention does not need to utilize Biotin (biotin) to label the digested fragments, and only needs the above-mentioned end repair method to carry out the subsequent adjacent connection step. Due to the omission of the Biotin labeling step, there is no need to use biotin magnetic beads for adsorption in the follow-up, thereby simplifying the operation steps, reducing costs, and improving the experimental success rate. At the same time, the Biotin labeling step makes it impossible for some fragments to be labeled, resulting in some digested fragments being discarded during the subsequent biotin magnetic beads adsorption, resulting in a significant reduction in genome coverage. In addition, the phenomenon of non-specific adsorption during biotin magnetic beads adsorption causes a high background and a significant increase in the false positive ratio, which seriously affects the test results. Therefore, the present invention can significantly improve the accuracy of the test results and the genome coverage through the above-mentioned end repair method.
[0080] S5, single cell isolation: isolate single cells and complete cell nucleus lysis to obtain single cell lysate.
[0081] This step first separates a single cell from the cell population, then lyses the cell nucleus to release the nuclear DNA, thereby ensuring that only genomic abnormalities in single cells are detected, avoiding interference from DNA in other cells, and ensuring the accuracy and reliability of single-cell genomic abnormality detection.
[0082] In some embodiments, the specific operation of this step is: washing and resuspending the product of step S4 with a PBS solution, using a capillary to draw 0.5 μL of a single cell and adding it to a PCR tube, adding a second lysis solution, and heat treating at 72° C. for 10 minutes to complete cell nucleus lysis to obtain a single cell lysate. The second lysis solution contains: 200 mM NaOH and 50 mM dithiothreitol.
[0083] S6, sample amplification, purification and fragment sorting: adding the aforementioned amplification system to the single cell lysate to perform DNA amplification, and obtaining a sorted amplified sample after purification and fragment sorting. The amplification system comprises: dNTPs, thio-ddNTPs, phi29 DNA polymerase, random primers and buffer required for PCR amplification.
[0084] This step is used to amplify the single cell genome, increase the amount of DNA, and after purification and fragment size screening, provide an effective template for subsequent library construction. It is well known in the art that the size of the gene fragment has an important impact on the detection resolution, effective detection of fragments, etc. At present, the optimization of shortening the gene fragment size to improve the amplification effect is mainly to shear the gene into smaller fragments before amplification, and then amplify the mode (the Meta method mentioned in Dip-C is to amplify after cutting the genome using Tn5 transposase), however, this method is costly, complicated to operate, and the risk of cross-reaction and non-specific amplification is relatively large.
[0085] The present invention is to improve the amplification effect, after a large number of designs and experimental verifications, and finally provides the amplification system comprising: dNTPs, thio ddNTPs, phi29 DNA polymerase, random primers and buffer required for PCR amplification. Among them, thio ddNTPs (α-thiol ddNTPs, thio dideoxynucleotide triphosphate) is a special nucleotide used for DNA sequencing and chain termination method (Sanger sequencing). They are similar to ordinary dNTPs deoxynucleotide triphosphate), but the key difference is that ddNTP lacks a hydroxyl (-OH) group at the 3' end, which makes them play a role in terminating chain extension during DNA synthesis. Therefore, the present invention designs to add thio ddNTPs to the amplification system, and by introducing thio ddNTPs to terminate the amplification in the amplification product, the purpose of reducing the length of the amplification product is achieved, and a high coverage, non-biased amplification sample is obtained to improve the detection resolution and the effective detection fragment ratio, and reduce noise and false positives. In addition, the exonuclease activity of the phi29 DNA polymerase used in the present invention also ensures the fidelity of the amplified DNA fragments, thereby improving the accuracy of the detection results.
[0086] In addition, it should be noted that the present invention uses thio-ddNTPs instead of ordinary ddNTPs. Due to the exonuclease activity of phi29 DNA polymerase, the cutting action of the exonuclease is on the phosphodiester bond, which is formed between the 3' hydroxyl group (-OH) of one nucleotide and the 5' phosphate group of the next nucleotide, making it impossible for ordinary ddNTPs to terminate amplification. However, the thio-modification carried on thio-ddNTPs can prevent the phi29 DNA polymerase from mistakenly thinking that it is an incorrect pairing and generating an enzyme cleavage reaction, thereby effectively preventing DNA amplification, producing smaller amplified fragments, and improving the amplification effect.
[0087] In this embodiment, when the molar concentration ratio of dNTPs to thio-ddNTPs in the amplification system is 1:2, DNA amplification can be effectively inhibited to produce suitable DNA amplification fragments. It can be understood that lower thio-ddNTPs cannot reduce the length of DNA amplification fragments, while too high thio-ddNTPs will cause DNA to fail to amplify.
[0088] In some embodiments, the fragment size of the amplified sample after sorting is 300bp-400bp.
[0089] S7, library construction and sequencing analysis: library construction and sequencing analysis are performed on the amplified samples after sorting.
[0090] An embodiment of the present invention further provides a single-cell genome abnormality detection kit, the kit comprising: formaldehyde, EGS, dNTPs, thio-ddNTPs, and phi29 DNA polymerase.
[0091] In some embodiments, the kit further comprises: formaldehyde, EGS, MboI restriction endonuclease, DNA polymerase I large fragment, T4 DNA ligase, random primers and buffer required for PCR amplification.
[0092] In some embodiments, the sequence of the random primer is NNNN*N*N, where * represents thiolation modification and N represents any nucleotide.
[0093] The present invention also provides the aforementioned amplification system and the use of the aforementioned kit in single-cell genome abnormality detection.
[0094] Next, the process and results of the present invention are described in detail in combination with experimental data and drawings:
[0095] Unless otherwise specified, the experimental methods, detection methods, and preparation methods disclosed in the present invention all adopt conventional techniques in molecular biology, biochemistry, chromatin structure and analysis, analytical chemistry, cell culture, recombinant DNA technology, and related fields in the art. The experimental methods used in the following examples, unless otherwise specified, were carried out according to conventional conditions or conditions recommended by the manufacturer.
[0096] The materials and reagents used in the following examples, unless otherwise specified, can be obtained from commercial sources. In addition, it should be noted that reagents with the same name are the same reagents, and the purchase source will be indicated when they appear for the first time, and will not be described later.
[0097] Terminology
[0098] In the present invention, "Uni-C technology" and "Uni-C method" both refer to the single-cell genome abnormality detection method of the present invention and can be used interchangeably.
[0099] Example 1
[0100] This embodiment provides a method for detecting single-cell genome abnormalities. The detection process is as follows: Figure 1 As shown, the following steps are included:
[0101] Step S1, cell cross-linking and fixation
[0102] (1) Collect 1×10 6 COLO320-DM cells (purchased from ATCC) were washed once with PBS solution (Hyclone, SH30256.FS).
[0103] (2) After resuspending the cells with 1 mL of PBS solution, first add formaldehyde solution (Sigma-Aldrich, 47608-250ML-F) with a final concentration of about 1% v / v. After fixing at room temperature for 10 min, immediately add 100 μL of 10% w / v BSA (bovine serum albumin, Sigma-Aldrich, V900933) and leave at room temperature for 5 min to terminate the primary cross-linking fixation. Centrifuge at 4°C and 1000 g for 5 min.
[0104] (3) After washing once with 1 mL of PBS solution, 10 μL of 100 mM EGS (ethylene glycol bis(succinimidyl succinate), Thermo Fisher Scientific, 21565) solution was added to the cell pellet. After incubation at room temperature for 20 min, glycine at a final concentration of 200 mM was added to terminate the secondary cross-linking fixation. The cells were centrifuged at 4°C and 1000 g for 5 min, and the cell pellet was obtained, which is the cross-linking fixation sample.
[0105] Step S2, lysis
[0106] (1) Add 1 mL of pre-cooled first buffer and 5 μL of protease inhibitor (Roche, 11836170001) to the cell pellet and centrifuge at 4°C and 1000 g for 5 min.
[0107] First buffer composition: 10 mM Tris-HCl pH 8.0 (Sango Biotech, B548127), 10 mM NaCl (Sigma-Aldrich, S9888) and 0.1 mg / mL BSA.
[0108] (2) Remove the supernatant solution after centrifugation, add 200 μL of pre-cooled first lysis solution and 5 μL of protease inhibitor to the cell pellet, incubate on ice for 15 min to initially lyse the cell membrane, and centrifuge at 4°C and 1000 g for 5 min.
[0109] First lysis buffer composition: 10 mM Tris pH 8.0, 10 mM NaCl and 0.2% w / v NP40 (ethylphenyl polyethylene glycol, Sigma-Aldrich, 127087-87-0).
[0110] (3) After centrifugation, the supernatant solution was removed, and 200 μL of 0.5% w / v SDS (sodium dodecyl sulfate solution, Sigma-Aldrich, 05030) was added to the cell pellet. After incubation at 65° C. for 10 min, the pellet was immediately placed on ice for 3 min to completely lyse the cell membrane.
[0111] (4) Add 100 μL of pre-cooled 5% v / v Triton-X 100 (Sigma-Aldrich, T8787) and incubate on ice for 5 min to terminate SDS lysis.
[0112] (5) Add an equal amount of the first buffer to dilute the solution obtained in (4) above to prevent cell adhesion in subsequent steps, and centrifuge at 4°C and 2500 g for 5 min.
[0113] It should be noted that in step (5), since there is too much internal liquid in the early stage, it needs to be removed by centrifugation. In order to avoid cell adhesion caused by centrifugal force, the first buffer added in this step contains BSA. BSA can form a layer of protein "barrier" on the inner wall surface of the centrifuge tube, and BSA can also bind to receptors or adhesion molecules on the cell surface to reduce direct contact between cells and the inner wall surface, prevent cells from adhering to the inner wall of the centrifuge tube due to centrifugal force during centrifugation and unable to be centrifuged to the bottom of the tube; more importantly, it prevents cell adhesion between a large number of cells centrifuged to the bottom of the tube due to centrifugal force.
[0114] It should be emphasized that the present invention has tried to add BSA in the centrifugation step before single cell separation, end repair and adjacent connection steps in order to prevent cell adhesion, but the results show that the improvement of cell adhesion is not ideal. When the centrifugation step to terminate the enzyme cleavage reaction is removed, the cell adhesion is significantly improved. In other words, removing the centrifugation step to terminate the enzyme cleavage reaction and using high temperature incubation to terminate the enzyme cleavage reaction are necessary steps for preventing cell adhesion in the present invention.
[0115] Step S3, enzyme digestion
[0116] (1) Add an appropriate amount of enzyme digestion system to the precipitate in step S2 and wash it once. The enzyme digestion system composition: 90 μl of ddH2O, 10 μl of 10×NEB buffer 2.0 (NEB B7002S).
[0117] (2) Add 90 μL of enzyme digestion system to the sample, resuspend, add 10 μL of restriction endonuclease MboI (NEB, R0147S, 20 units / μl), and mix well.
[0118] (3) Place the sample in a 37°C water bath and incubate overnight to achieve the enzyme digestion effect.
[0119] (4) After enzyme digestion, the sample was placed in a 65°C PCR instrument and incubated for 20 minutes to terminate the enzyme digestion reaction, and then cooled to room temperature.
[0120] At the same time, 10 μL of the digested sample was taken, the cells were broken up with proteinase K, and the DNA was extracted and then the digestion effect was identified by DNA gel electrophoresis. Figure 2 As shown, DNA fragments of different sizes were generated after the genome was treated with restriction endonuclease MboI.
[0121] Step S4: end repair and adjacent connection
[0122] (1) Add the end repair system to the digested product, mix well, and incubate in a 37°C water bath for 1 h to complete the end repair.
[0123] The end repair system consisted of 81 μL ddH2O, 10 μL 10×NEB Buffer 2.0, 3 μL dNTPs (NEB, N0447S) and 6 μL DNA polymerase I Klenow fragment (DNA polymerase I large fragment, NEB, M0210).
[0124] (2) Add the ligation reaction system to the end repair product, mix well, and react overnight at room temperature to reconnect adjacent DNA fragments.
[0125] The ligation reaction system consisted of: 270 μL ddH2O, 50 μL 10% Triton-X 100, 25 μL T4 DNA Ligase (T4 DNA ligase, Thermo Fisher Scientific, EL0011) and 50 μL 10×Ligase Buffer (ligase matching buffer).
[0126] After the proximity ligation reaction, 10 μL of the ligation sample was taken, the cells were disrupted with proteinase K, and the DNA was extracted and the ligation effect was identified by DNA gel electrophoresis. Figure 3 As shown in the figure, the fragment size of the digested sample increased significantly after end repair and proximity ligation, indicating that the ligation was successful.
[0127] Step S5, single cell isolation
[0128] (1) The product of step S4 was centrifuged at 4°C and 2500 g for 5 min, the supernatant was removed, and the cells were washed once with PBS solution, and then resuspended with PBS.
[0129] (2) Use a capillary to aspirate 0.5 μL of single cells and add them to a PCR tube (Axygen, PCR-02-LC).
[0130] (3) Add 2 μL of the second lysis solution to the PCR tube, shake it in a metal bath for 3 min, mix it evenly, put it in a PCR instrument, and heat treat it at 72° C. for 10 min to lyse the cell nuclei to obtain a single cell lysate.
[0131] The second lysis buffer components: 200 mM NaOH (Sigma-Aldrich, 72068) and 50 mM DTT (dithiothreitol, Sigma-Aldrich, D9779).
[0132] Step S6: sample amplification, purification and fragment sorting
[0133] (1) Add 2 μL of 200 mM HCl to the single-cell lysate and mix the sample by shaking in a metal bath for 3 min to neutralize the pH of the sample.
[0134] (2) Add the amplification system to the sample, mix well, and place in a PCR instrument for amplification at 42°C for 2 h.
[0135] Amplification system composition: 10 μL ddH2O, 0.5 μL dNTPs (10 mM each), 1 μL α-thiol ddNTPs (10 mM each), 2 μL Primer 6N (100 μM), 1 μL phi29 MAX DNA Polymerase (Thermo Fisher Scientific, A39390), 2 μL phi29 MAX DNA Polymerase Reaction Buffer (10×), where α-thiol ddNTPs are prepared by mixing 2',3'-dideoxyadenosine-5'-O-(1-thiotriphosphate) (Trilink, N-8009), 2',3'-dideoxyguanosine-5'-O-(1-thiotriphosphate) (Trilink, N-8011), 2',3'-dideoxycytosine-5'-O-(1-thiotriphosphate) (Trilink, N-8010) and 3'-deoxythymidine-5'-O-(1-thiotriphosphate) (Trilink, N-8012) at a final concentration ratio of 1:1:1:1; Primer 6N is a random primer with a primer sequence of NNNN*N*N, where * indicates thio modification and N represents any nucleotide, which can be adenine (A), cytosine (C), guanine (G) or thymine (T).
[0136] After PCR amplification, 1 μL of the amplified product was taken and the amplification effect was identified by DNA gel electrophoresis. Figure 4 As shown, in this embodiment, single cells separated from adjacent ligation samples are subjected to PCR amplification, and DNA sequences of different fragment sizes can be amplified. In addition, using α-thiol ddNTPs to bind to the amplified product to terminate the amplification can result in significantly smaller amplified fragments, with the main fragments being between 100 bp and 2000 bp, thereby increasing the coverage of the amplified genome.
[0137] (3) Amplification sample purification
[0138] The DNA of the amplified samples was purified using a DNA purification kit (TD413-200, Jianshi Biotechnology). The specific operation steps are detailed in the kit manual and will not be repeated here.
[0139] (4) Fragmentation sorting of purified samples
[0140] VAHTS DNA Clean Beads (Vazyme, N411) were used to sort the amplified DNA fragments of 300 bp-400 bp from the purified single-cell amplified fragments. The specific operation steps are as follows:
[0141] A. After equilibration of VAHTS DNA Clean Beads to room temperature in advance, pipette 70 μL of magnetic beads into 100 μL of sample and incubate at room temperature for 5 minutes.
[0142] B. Use a magnetic stand to adsorb the magnetic beads. After the solution is clarified, transfer the supernatant to a new PCR tube and discard the magnetic beads.
[0143] C. Pipette 20 μL of magnetic beads into the supernatant and incubate at room temperature for 5 minutes. Use a magnetic stand to adsorb the magnetic beads and discard the supernatant after the solution is clear.
[0144] D. Add 200 μL of 80% ethanol to the magnetic beads and wash twice by rotating.
[0145] E. After removing 80% ethanol, let it stand at room temperature for 5 minutes to allow the ethanol to evaporate completely.
[0146] F. Add 20 μL ddH2O, mix well, and incubate at room temperature for 2 minutes. Use a magnetic stand to adsorb the magnetic beads, wait for the solution to become clear, and then aspirate the supernatant and transfer it to a new centrifuge tube to obtain the amplified sample after sorting.
[0147] S7, Library construction and sequencing analysis
[0148] S7.1 Library construction
[0149] use The DNA library was constructed using the Universal Pro DNA Library Prep Kit for MGI (Vazyme, NDM627), as detailed below:
[0150] (1) End repair
[0151] Add 5μL End Prep Enzyme, 10μL End Prep Buffer and 25μL ddH2O to the amplified sample after sorting, mix the sample and put it into the PCR instrument. The PCR program is shown in the following table:
[0152] Table 1 End-repair PCR program
[0153] temperature time Heating cover 105℃ On 30℃ 20min 65℃ 15min 4℃ Hold
[0154] (2) Adapter connection
[0155] Add the following reagents to the end repair product: 25μL Rapid Ligation buffer 2, 5μL Radin DNA ligase and 5μL DNA Adapter, mix the sample and put it into the PCR instrument. The PCR program is shown in the following table:
[0156] Table 2 Adapter ligation PCR program
[0157] temperature time Heating cover 105℃ On 20℃ 15min 4℃ Hold
[0158] The DNA Adapter sequence is:
[0159] 5'-TTGTCTTCCTAAGGAACGACATGGCTACGATCCGACTT-3' (SEQ ID NO. 1);
[0160] 5'-AGTCGGAGGCCAAGCGGTCTTAGGAAGACAA-3' (SEQ ID NO. 2);
[0161] (3) Sample purification
[0162] A. After the beads are equilibrated to room temperature, vortex and mix the VAHTSDNA Clean Beads.
[0163] B. Pipette 60 μL of VAHTS DNA Clean Beads into 100 μL of Adapter Ligation product and mix thoroughly by vortexing or pipetting gently 10 times.
[0164] C. Incubate at room temperature for 5 minutes.
[0165] D. Centrifuge the PCR tube briefly and place it on a magnetic rack to separate the magnetic beads and liquid. After the solution becomes clear (about 5 minutes), carefully remove the supernatant.
[0166] E. Keep the PCR tube in the magnetic rack, add 200 μL of freshly prepared 80% ethanol to rinse the magnetic beads, incubate at room temperature for 30 seconds, and carefully remove the supernatant.
[0167] F. Repeat the 80% ethanol rinse for a total of two times.
[0168] G. Keep the PCR tube in the magnetic rack at all times, open the lid and air-dry the magnetic beads for 5-10 minutes until no ethanol remains.
[0169] H. Remove the PCR tube from the magnetic stand and elute with 20 μL ddH2O.
[0170] (4) Library amplification
[0171] Add 5μL PCR Primer Mix and 25μL VAHTS HiFi Amplification Mix solution to the purified sample, mix well and place the sample in a PCR instrument for library amplification. The PCR amplification program is shown in the following table:
[0172] Table 3 PCR amplification program
[0173]
[0174] The PCR Primer Mix contains primers for PCR amplification, wherein:
[0175] The forward primer is: 5′-GAACGACATGGCTACGATCCGACTT-3′ (SEQ ID NO. 3);
[0176] The reverse primer included: 5′-TGTGAGCCAAGGAGTTGAGCACCTCTCTTGTCTTCCTAAGACCGCTTGGCCTCCGACT-3′ (SEQ ID NO. 4);
[0177] 5'-TGTGAGCCAAGGAGTTGCAAGTTCACATTGTCTTCCTAAGACC GCTTGGCCTCCGACT-3' (SEQ ID NO. 5);
[0178] 5'-TGTGAGCCAAGGAGTTGCGCGGAGCATTTGTCTTCCTAAGACC GCTTGGCCTCCGACT-3' (SEQ ID NO. 6);
[0179] 5'-TGTGAGCCAAGGAGTTTGGCGTGAGTATTTGTCTTCCTAAGACCGCTTTGGCCTCCGACT-3' (SEQ ID NO. 7).
[0180] (5) Library purification
[0181] A. After the beads are equilibrated to room temperature, vortex and mix the VAHTSDNA Clean Beads.
[0182] B. Pipette 60 μL of VAHTS DNA Clean Beads into 100 μL of Adapter Ligation product and mix thoroughly by vortexing or pipetting gently 10 times.
[0183] C. Incubate at room temperature for 5 minutes.
[0184] D. Centrifuge the PCR tube briefly and place it on a magnetic rack to separate the magnetic beads and liquid. After the solution becomes clear (about 5 minutes), carefully remove the supernatant.
[0185] E. Keep the PCR tube in the magnetic rack, add 200 μL of freshly prepared 80% ethanol to rinse the magnetic beads, incubate at room temperature for 30 seconds, and carefully remove the supernatant.
[0186] F. Repeat the 80% ethanol rinse for a total of two times.
[0187] G. Keep the PCR tube in the magnetic rack at all times, open the lid and air-dry the magnetic beads for 5-10 minutes until no ethanol remains.
[0188] H. Remove the PCR tube from the magnetic stand and elute with 20 μL ddH2O.
[0189] After library purification, 1 μL of sample was taken to identify the library construction effect by DNA gel electrophoresis. Figure 5 As shown, in this example, the amplified sample was used for library construction, and a fragment of about 500 bp in size was successfully obtained.
[0190] S7.2 Sequencing analysis
[0191] The constructed library samples were sequenced by BGI, and the sequencing results were analyzed.
[0192] (1) Analysis of SNP and INDEL detection results:
[0193] For SNP and INDEL detection, the raw read pairs were initially processed using FASTP (version: 0.23.2) to remove residual sequencing adapter sequences. To mitigate background noise associated with Hi-C junctions, we filtered out all read pairs containing the MboI restriction site junction "GATCGATC". Subsequently, these filtered read pairs were aligned to the reference genome GRCh37 or GRCm38 using BWA (version: 0.7.17). The aligned BAM files were sorted using SAMTOOLS (version: 1.15.1) and duplicate reads were removed by SAMBAMBA (version: 0.6.6). Next, the base quality scores were recalibrated using the BaseRecalibrator tool (from GATK, version 4.2.2), and then SNPs and indels were detected using HaplotypeCaller (from GATK, version 4.2.2). Statistical analysis of the variation data in each single-cell VCF was then performed. Variants present in two or more VCF files will be considered true and retained, while variants appearing in only one VCF file will be filtered out.Finally, the R package MutationalPatterns (version 3.12.0) was used to perform statistics on base substitution types, mutation spectra, 96 mutation spectra, and Indel types.
[0194] (2) Copy number variation analysis:
[0195] Using the de-duplicated BAM files from the SNP and INDEL detection steps, CNVs were called using the WGS mode of CNVkit (version: 0.9.10): “cnvkit.py batch-m wgs”. For details, see the software manual https: / / cnvkit.readthedocs.io / en / stable / .
[0196] (3) Construction of single-cell genome-wide chromatin interaction matrix
[0197] Uni-C raw read pairs were initially processed using FASTP (version: 0.23.2) to remove residual sequencing adapter sequences. After filtering, read pairs were aligned to the reference genome using the “mem” module of BWA (version: 0.7.17) with the parameters “-5SP-T0”. After alignment, we converted the resulting SAM files into the PAIRSAM format using the “parse” module of PAIRTOOLS (version: 0.3.0) with the specific parameters set to “--min-mapq 40 --walks-policy 5unique --max-inter-alignment-gap 30”. The pairam files were then sorted and deduplicated using the “sort” and “dedup” modules of PAIRTOOLS, respectively. After deduplication, the “split” module of PAIRTOOS was used to convert the deduplicated PAIRSAM files into the PAIRS format. These final pairwise files are used to generate chromatin interaction matrices using tools such as JUICERTOOLS (version: 1.9.9) or COOLER (version: 0.9.3).
[0198] Based on the single-cell genome abnormality detection method provided in the above embodiments, the present invention evaluates the effectiveness of the detection method of the present invention and the accuracy of the detection results through analysis of different experiments and detection results.
[0199] See attached Figure 6 , the method of the present invention (Uni-C technology) and the existing MGA-Seq technology were used to detect and analyze abnormal genome amplification in cells, and a chromatin interaction matrix was prepared. MGA-Seq technology is a method for detecting multiple genome structural variations at the level of a large number of cells. The results showed that there was abnormal genome amplification in some regions on chromosome 8 in the cells, and the genes related to the amplified region interacted with multiple chromosomes. And this result is consistent with the detection results at the level of a large number of cells, indicating that the detection results at the single cell level obtained using the detection method of the present invention have high accuracy ( Figure 6A and B). It is further explained that the method of the present invention can detect abnormal gene amplification in cells, and can analyze and identify abnormal chromatin interactions caused by genome amplification.
[0200] See attached Figure 7 , the method of the present invention (Uni-C technology) and the existing MGA-Seq technology were used to detect and analyze the genomic copy number variation in the colorectal cancer cell line COLO320 DM. The results showed that there was abnormal amplification of the copy number of genes related to some regions of chromosome 8 in the cells, including the proto-oncogene Myc gene and its transcriptional regulatory gene PVT1. The amplification of this gene has a promoting effect on the occurrence and development of cancer and poor tumor prognosis. This result is consistent with the results in a large number of cells, which shows the accuracy of the detection results of the present invention ( Figure 7 A and B).
[0201] See Figure 8 , the method of the present invention (Uni-C technology) and the existing MGA-Seq technology were used to detect and analyze SNPs and INDELs in the colorectal cancer cell line COLO320 DM. The results showed that based on the SNP and INDEL detection at the single cell level, a total of 4127543 SNPs and INDELs were detected. Among them, 3373118 SNPs and INDELs overlapped with the detection results at the level of a large number of cells, while 754425 SNPs and INDELs were detected only in the Uni-C method at the single cell level ( Figure 8 A). This shows that the strong heterogeneity in tumor cells causes some important detection information to be covered in the detection of a large number of cells, resulting in failure to detect. Therefore, the Uni-C detection method at the single-cell level has greater advantages in genomic abnormality detection than a large number of cells. In addition, a detailed analysis of SNPs on different chromosomes in cells showed that there were more C>T and T>C SNPs on chromosome 1, as well as some C>AC>GT>AT>G SNPs, and the Uni-C detection at the single-cell level was consistent with the detection results of a large number of cell samples ( Figure 8 B and C). This shows that the detection method at the single cell level of the present invention has high accuracy.
[0202] See Fig. 9 , the method of the present invention (Uni-C) was used to detect and analyze the genomic structural variation in single cells, and the accuracy was compared using the detection results of a large number of cells. The results showed that there was a balanced translocation between chromosomes 16 and 1 (first row), an unbalanced translocation between chromosomes 11 and 2 (second row), an inversion translocation on chromosome 9 (third row) and duplication (fourth row) and a deletion on chromosome 12 (fifth row) in the cells. This result is consistent with the structural variation detected in a large number of cells ( Fig. 9AC).
[0203] In addition, the present invention also incorporates existing detection methods such as DIP-C (Method A) and HIRES (Method B) as comparative experiments to evaluate the improvements of the detection method of the present invention in terms of gene coverage, limited detection fragment ratio, detection resolution, etc. It should be noted that the detection methods of DIP-C (Method A) and HIRES (Method B) are both existing conventional technologies. The specific operation methods can be found in relevant literature and will not be described in detail here. The following comparative results are included:
[0204] See attached Fig.10 , the method of the present invention (Uni-C) and Method A were used to detect and analyze genomic abnormalities at the single-cell level, and a chromatin interaction matrix was drawn based on the analysis results. The chromosome interaction detection results of the Uni-C method at the single-cell level and the Method A method at the single-cell level were compared at the same position in the interaction heat map at 250kb, 100kb, 25kb and 10kb resolutions. The results showed that the resolution of the detection results using the Uni-C method was ( Fig.10 The resolution of the detection results of Method A is significantly higher than that of Method A ( Fig.10 B) and detected more chromatin interactions.
[0205] See attached Fig.11 , the genome coverage of the method of the present invention (Uni-C) and the method of Method A was analyzed. The results showed that the genome coverage of the Uni-C method for genome abnormality detection was about 80%-95%, which was significantly higher than the genome coverage of the Method A method under a large number of cells (30%-70%). This shows that the detection method of the present invention can obtain higher genome coverage.
[0206] See attached Fig.12 , the proportion of effective interaction fragments after de-redundancy of the method of the present invention (Uni-C) and the methods of Method B and Method A was analyzed. The results showed that the proportion of non-repetitive read fragments of the Uni-C method accounted for about 60%-75% of the total detected fragments, which was significantly higher than that of Method B (20%-50%) and Method A (15%-45%). This shows that compared with the prior art, the detection method of the present invention has a higher proportion of effective detected fragments.
[0207] See attached Fig.13, the proportion of long-range interaction fragments (>10kb) of the method of the present invention (Uni-C) and the methods of Method B and Method A were analyzed. The results showed that the proportion of long-range interaction fragments of the Uni-C method accounted for about 9%-13% of the total detected fragments, while that of Method B and Method A was only 3%-7% and 1%-4%, respectively. This shows that the detection method of the present invention can obtain a higher proportion of long-range interaction fragments for genomic abnormality detection, thereby significantly improving the detection effect.
[0208] In summary, the detection method provided by the present invention improves the cross-linking strength and stability by fixing the sample in a formaldehyde-EGS double cross-linking mode, avoids non-specific cross-linking caused by subsequent de-cross-linking, and reduces detection noise and false positive phenomena; high-temperature incubation is used to terminate the enzyme cleavage reaction, which is used to avoid the phenomenon that cells are prone to adhesion and aggregation in the traditional centrifugation step, reduce data confusion, poor data quality, false positives or false negatives caused by cell adhesion, and reduce the difficulty of single-cell separation operation experiments; in the process of single-cell genome amplification, thio-ddNTPs are introduced to bind to the amplification product to terminate the amplification, and a high-coverage, non-biased amplification sample is obtained, thereby improving the detection resolution and the effective detection fragment ratio, and reducing noise and false positives; at the same time, phi29 DNA polymerase is used for amplification to ensure the fidelity of the amplification product.
[0209] Although the content of the present invention has been described in detail through the above preferred embodiments, it should be appreciated that the above description should not be considered as a limitation of the present invention. After reading the above content, it will be apparent to those skilled in the art that various modifications and substitutions of the present invention will occur. Therefore, the protection scope of the present invention should be limited by the appended claims.
Claims
1. A method for detecting single-cell genome abnormalities, characterized in that: The following steps are involved: S1, cross-linking fixation: formaldehyde is added to the sample for primary cross-linking fixation, and then EGS is added for secondary cross-linking fixation to obtain a cross-linked fixed sample; S2, lysis: performing cell membrane lysis treatment on the cross-linked fixed sample; S3, enzyme digestion: adding restriction endonucleases to the cell membrane lysed samples for enzyme digestion reaction to fragment the samples, and high temperature incubation is used to terminate the enzyme digestion reaction; S4, end repair and proximity ligation: repair the DNA ends of the fragmented samples and reconnect the adjacent DNA fragments using DNA ligase; S5, single cell separation: separate single cells and complete cell nucleus lysis to obtain single cell lysate; S6, sample amplification and fragment sorting: adding an amplification system to the single cell lysate to amplify DNA, and obtaining a sorted amplified sample after purification and fragment sorting; S7, library construction and sequencing analysis: performing library construction and sequencing analysis on the amplified samples after sorting; Wherein, the amplification system comprises: dNTPs, thio-ddNTPs, and phi29 DNA polymerase.
2. The single-cell genome abnormality detection method according to claim 1, characterized in that: In step S6, the fragment size of the amplified sample after sorting is 300bp-400bp.
3. The single-cell genome abnormality detection method according to claim 1, characterized in that: In step S6, in the amplification system, the molar concentration ratio of dNTPs to thio-ddNTPs is 1:
2.
4. The single-cell genome abnormality detection method according to claim 1, characterized in that: The specific steps include: S1, cross-linking fixation: collect cell samples, wash and resuspend them with PBS solution, add formaldehyde solution with a final concentration of 1% v / v, incubate at room temperature for 10 minutes, and then add BSA solution with a final concentration of 1% w / v to terminate the primary cross-linking fixation; After centrifugation and washing, 10 μL of 100 mM EGS solution was added, and after incubation at room temperature for 20 min, a glycine solution with a final concentration of 200 mM was added to terminate the secondary cross-linking fixation. After centrifugation, the precipitate was collected to obtain a cross-linked fixed sample; S2, lysis: add 200 μL of pre-cooled first lysis solution and 5 μL of protease inhibitor to the cross-linked fixed sample to preliminarily lyse the cell membrane; after centrifugation to remove the supernatant, add 200 μL of 0.5% w / v sodium dodecyl sulfate solution, incubate on ice for 3 minutes after 10 minutes in a 65°C water bath to completely lyse the cell membrane; then add 100 μL of pre-cooled 5% v / v Triton X-100, incubate on ice for 5 minutes to terminate the lysis; S3, enzyme digestion: add an enzyme digestion system containing restriction endonucleases to the product of step S2, mix well, incubate at 37°C overnight to fragment the sample, and terminate the enzyme digestion reaction by incubating at 65°C for 20 minutes; S4, end repair and adjacent ligation: Add the end repair system to the enzyme digestion product and react at 37°C for 1 hour to complete the end repair; Add a ligation reaction system containing DNA ligase to the end repair product and react overnight at room temperature to reconnect adjacent DNA fragments; S5, single cell separation: wash and resuspend the product of step S4 with PBS solution, use a capillary to draw 0.5 μL of single cells and add them to a PCR tube, add the second lysis solution, heat treat at 72°C for 10 min to complete cell nuclear lysis, and obtain single cell lysate; S6, sample amplification, purification and fragment sorting: adding the amplification system to the single cell lysate, amplifying at 42° C. for 2 h, purifying the product and sorting the fragments to obtain a sorted amplified sample; S7, library construction and sequencing analysis: library construction and sequencing analysis are performed on the sorted samples.
5. The single-cell genome abnormality detection method according to claim 4, characterized in that: In step S3, the restriction endonuclease comprises any one of MboI, HindIII, DpnII, NcoI, EcoRI, and NlaIII; in step S4, DNA end repair is completed using any one of DNA polymerase I large fragment, Taq DNA polymerase, or DNA polymerase I; and the DNA ligase comprises T4 DNA ligase.
6. The single-cell genome abnormality detection method according to claim 4, characterized in that: The first lysing solution comprises: 10 mM Tris, 10 mM NaCl and 0.2% w / v ethylphenyl polyethylene glycol; The second lysis solution contains: 200 mM NaOH and 50 mM dithiothreitol.
7. A single-cell genome abnormality detection kit, characterized in that: The kit comprises: formaldehyde, EGS, dNTPs, thio-ddNTPs, and phi29 DNA polymerase.
8. The single-cell genome abnormality detection kit according to claim 7, characterized in that: The kit also contains: MboI restriction endonuclease, DNA polymerase I large fragment, T4 DNA ligase, random primers and buffer required for PCR amplification.
9. The single-cell genome abnormality detection kit according to claim 8, characterized in that The sequence of the random primer is NNNN*N*N, where * represents thiolation modification and N represents any nucleotide.
10. Use of the kit according to any one of claims 7 to 9 in detecting single-cell genome abnormalities.
